Your browser doesn't support javascript.
loading
Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment.
Takei, Satomi; Ai, Tomohiko; Yamamoto, Takamasa; Igawa, Gene; Kanno, Takayuki; Tobiume, Minoru; Hiki, Makoto; Saito, Kaori; Khasawneh, Abdullah; Wakita, Mitsuru; Misawa, Shigeki; Miida, Takashi; Okuzawa, Atsushi; Suzuki, Tadaki; Takahashi, Kazuhisa; Naito, Toshio; Tabe, Yoko.
Afiliación
  • Takei S; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
  • Ai T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Yamamoto T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Igawa G; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
  • Kanno T; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
  • Tobiume M; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hiki M; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Saito K; Department of Emergency Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Khasawneh A; Department of Cardiovascular Biology and Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Wakita M; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Misawa S; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Miida T; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
  • Okuzawa A; Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.
  • Suzuki T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Takahashi K; Department of Research Support Utilizing Bioresource Bank, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Naito T; Department of Coloproctological Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Tabe Y; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
PLoS One ; 17(9): e0274181, 2022.
Article en En | MEDLINE | ID: mdl-36107911

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Japón